The Asco Post

Radiation oncology

The Role of Integrated Palliative Care in Radiation OncologySeptember 1, 2014, Volume 5, Issue 14

Three years ago, Dana-Farber Cancer Institute and Brigham and Women’s Hospital in Boston, launched a Supportive and Palliative Radiation Oncology (SPRO) program to integrate generalist palliative oncology services, including the physical, psychosocial, and spiritual aspects of care, into radiatio...

Read More

FDA Approves Radioactive Diagnostic Imaging Agent to Help Determine the Extent of Head and Neck Cancer in the BodyJune 25, 2014, Volume 5, Issue 10

The U.S. Food and Drug Administration has approved a new use for technetium 99m tilmanocept (Lymphoseek Injection), a radioactive diagnostic imaging agent used to help doctors determine the extent to which squamous cell carcinoma has spread in the body’s head and neck region. In 2013, tilmanocept...

Read More

Georgetown Researchers Study Nonsurgical, Minimally Invasive Approach to Benign Prostatic HyperplasiaApril 15, 2014, Volume 5, Issue 6

Physicians at MedStar Georgetown University Hospital and Georgetown University Medical Center, Washington, DC, are studying the safety and effectiveness of prostate artery embolization in men with enlarged prostate glands and urinary obstruction. According to the National Institutes of Health, be...

Read More

American College of Radiology Issues Statement on Budgetary Efforts to Curtail Imaging and Radiation Oncology Self-ReferralApril 15, 2014, Volume 5, Issue 6

The American College of Radiology (ACR) recently issued a statement applauding steps to reign in medical imaging and radiation oncology self-referral included in the President’s fiscal year 2015 budget. However, prior authorization for imaging services, also included in the FY2015 budget, is unne...

Read More

Radiation Oncology Institute Awards $200,000 Grant to Christopher Slatore, MDFebruary 15, 2014, Volume 5, Issue 3

The Radiation Oncology Institute (ROI) has named Christopher G. Slatore, MD, recipient of a $200,000 award, distributed over 2 years, for a project to examine the comparative value of radiation therapy and patient outcomes among patients with lung cancer. Dr. Slatore is Assistant Professor in the...

Read More

NewYork-Presbyterian/Columbia University Medical Center Opens Irving Radiation Oncology CenterDecember 1, 2013, Volume 4, Issue 19

NewYork-Presbyterian/Columbia University Medical Center has opened its new Irving Radiation Oncology Center, part of the medical center’s Herbert Irving Comprehensive Cancer Center. The 12,500-square-foot facility provides precision radiation therapies and advanced diagnostic imaging for children...

Read More

Vertebral Compression Fracture Risk Increased After Spinal Stereotactic Body Radiotherapy November 15, 2013, Volume 4, Issue 18

In a study reported in Journal of Clinical Oncology, Arjun Sahgal, MD, of Princess Margaret Cancer Centre in Toronto, and colleagues evaluated the occurrence of vertebral compression fractures in patients undergoing spinal stereotactic body radiotherapy.1 Vertebral compression fractures occurred ...

Read More

ASTRO Offers Five Recommendations as Part of Choosing Wisely CampaignOctober 15, 2013, Volume 4, Issue 16

The American Society for Radiation Oncology (ASTRO) released its list of five radiation oncology-specific treatments that are commonly ordered but may not always be appropriate as part of the national Choosing Wisely® campaign, an initiative of the American Board of Internal Medicine Foundation. ...

Read More

SEER Analysis Shows Increased Survival with Surgery and Radiation Therapy in Metastatic Gastric Cancer July 10, 2013, Volume 4, Issue 11

A Surveillance, Epidemiology, and End Results (SEER) database analysis reported by Ravi Shridhar, MD, PhD, and colleagues in Cancer indicates that patients receiving surgery and radiation therapy for metastatic gastric cancer have prolonged survival compared with those receiving either alone or n...

Read More

Refractory Liver Metastases Yield to Yttrium-90 Radioembolization May 15, 2013, Volume 4, Issue 8

In patients with unresectable hepatic metastases from metastatic melanoma and neuroendocrine tumors, radioembolization led to good outcomes in studies from Emory University School of Medicine reported at the 38th Society of Interventional Radiology Annual Scientific Meeting, held recently in New ...

Read More

University of Michigan Launches New Cardio-oncology ProgramMay 15, 2013, Volume 4, Issue 8

The University of Michigan Samuel and Jean Frankel Cardiovascular Center, working with specialists at the University of Michigan (U-M) Comprehensive Cancer Center, has launched Michigan’s first cardio-oncology clinic, a program designed to prevent or minimize heart damage caused by chemotherapy a...

Read More

Elekta Receives FDA 510(k) Clearance Following Launch of New Versa HD Radiation Therapy System May 1, 2013, Volume 4, Issue 7

Elekta recently received 510(k) clearance from the FDA, allowing the company to begin shipping and installation of all components of the Versa HD system within the United States. The Versa HD radiation system, featuring high-precision beam shaping and tumor targeting, is capable of delivering rad...

Read More

Radiation, Still Misunderstood after All These Years April 15, 2013, Volume 4, Issue 6

Over the past few decades, radiation therapies have rapidly advanced, due, in large part, to an increasing technologic armamentarium. Among modern science’s most impressive machines, for example, 220-ton particle accelerators can generate near-light-speed beams of protons, with sniper-like precis...

Read More

On Radiation and Cancer RiskMarch 1, 2013, Volume 4, Issue 4

We owe our life to radiation. The universe was created in a thermonuclear explosion, and continued existence of life on Earth depends on plants using chlorophyll to capture light energy emitted by the sun (and exploding supernovas) and converting it into chemical energy, with the subsequent conve...

Read More

No Difference in Toxicity with Proton Radiotherapy vs Less Costly Intensity-modulated Radiotherapy February 1, 2013, Volume 4, Issue 2

A national sample of Medicare beneficiaries treated for prostate cancer with intensity-modulated radiation therapy or proton radiotherapy found that proton radiotherapy “was rare and expensive and associated with only a modest and transient reduction in genitourinary toxicity,” reported James B. ...

Read More

ASTRO Names Neurosurgeon Mark P. Carol, MD, 2012 Honorary MemberDecember 15, 2012, Volume 3, Issue 18

The American Society for Radiation Oncology (ASTRO) has named Mark P. Carol, MD, a distinguished leader in the fields of intensity-modulated radiation therapy (IMRT) and image-guided radiation therapy (IGRT), as its 2012 Honorary Member. The title of Honorary Member is the highest honor ASTRO bes...

Read More

Plenary Session Included Findings on Partial- vs Whole-breast Techniques and Patient Beliefs about RadiotherapyDecember 15, 2012, Volume 3, Issue 18

When the dates were picked for the 54th Annual Meeting of the American Society for Radiation Oncology (ASTRO), no one could have anticipated that the meeting would coincide with Hurricane Sandy’s devastation of parts of the northeast. As the storm approached on Monday and Boston shut down its tra...

Read More

Radiation Oncologists Are Discussing Infertility Risks with Young PatientsApri 15, 2012, Volume 3, Issue 6

More than 80% of radiation oncologists discuss the impact of cancer treatments on fertility with their patients of childbearing age. This can lead to improved quality of life for young patients with cancer, according to a study in Practical Radiation Oncology.1 In the past, the clinical focus fo...

Read More

Rising Costs in Radiation Oncology Linked to Medicare CoverageMarch 15, 2012, Volume 3, Issue 5

In the ongoing debate over how to control rising cancer care costs, it is vital to identify usage patterns of expensive new technologies. A recent study examined the relationship between Medicare reimbursement and the increasing use of intensity-modulated radiation therapy (IMRT).1 The ASCO Post ...

Read More

Fewer Rectal Side Effects with IMRT than with 3D-CRT for Prostate CancerNovember 15, 2011, Volume 2, Issue 17

The use of intensity-modulated radiation therapy (IMRT) is associated with fewer acute and late toxic effects than is three-dimensional conformal radiation therapy (3D-CRT) in men with localized prostate cancer, according to preliminary analysis of the Radiation Therapy Oncology Group (RTOG) 0126...

Read More

Preoperative Chemoradiotherapy May Extend Survival for Patients with Esophagogastric Junction AdenocarcinomaNovember 15, 2011, Volume 2, Issue 17

Several American and European clinical trials have yielded mixed results on the survival advantage of preoperative chemoradiotherapy for patients with locally advanced esophagogastric junction adenonocarcinoma. However, a distinguished panel at the 2011 ASTRO Annual Meeting did agree that surgery...

Read More

Despite Challenges, Combined-modality Therapy Warranted for Locally Recurrent Colorectal CancerNovember 15, 2011, Volume 2, Issue 17

Encouraging outcomes have been achieved with a combined-modality treatment approach for patients with locally recurrent colorectal cancer in both curative and palliative settings, although room for improvement remains. During a session presented at the American Society for Radiation Oncology (AST...

Read More

Hypofractionated Radiotherapy Effectively Controls High-risk Prostate CancerNovember 15, 2011, Volume 2, Issue 17

The use of hypofractionated intensity-modulated radiotherapy (IMRT) appears to be a reasonable option for men with intermediate- to high-risk prostate cancer,1 reported Alan Pollack, MD, Chairman of Radiation Oncology at the University of Miami Miller School of Medicine in Miami and lead investig...

Read More
More on Twitter